Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet‐induced obesity

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-07962024 · 62 citations
2. 2NLRP3 Inflammasome Activation in Chronic Inflammatory Diseases and Emerging Causative Role of Gut Dysbiosis2025
3. 3NLRP3 Inflammasome Activation in Chronic Inflammatory Diseases and Emerging Causative Role of Gut Dysbiosis2025
4. 4NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases2020 · 94 citations
5. 5NLRC3 deficiency exacerbates high-fat diet-induced enteric nervous system injury and colonic motility dysfunction in mice via activating NF-κB signaling pathway2026